Table 2.
HC | MCI-AD | MCI-LB | Group comparison | |
---|---|---|---|---|
Delta power | 14.1 [11.3, 17.0] | 14.1 [11.8, 16.3] | 14.9 [12.7, 17.1] | F(2, 102) = 0.8, p = 0.47 |
Theta power | 5.7 [4.6, 6.9] | 7.0 [6.0, 8.1] | 8.8 [7.2, 10.3] | F(2, 102) = 4.8, p = 0.01 |
p(HC,MCI-AD) = 0.19 p(HC,MCI-LB) = 0.004 p(MCI-AD,MCI-LB) = 0.46 | ||||
Pre-alpha power | 13.3 [9.9, 16.7] | 19.6 [16.1, 23.1] | 28.8 [24.2, 33.4] | F(2, 102) = 16.0, p < 0.001 |
p(HC,MCI-AD) = 0.006 p(HC,MCI-LB) < 0.001 p(MCI-AD,MCI-LB) = 0.02 | ||||
Alpha power | 39.9 [34.1, 45.6] | 33.6 [29.3, 37.9] | 28.3 [23.6, 33.1] | F(2, 102) = 5.5, p = 0.005 |
p(HC,MCI-AD) = 0.39 p(HC,MCI-LB) = 0.001 p(MCI-AD,MCI-LB) = 0.07 | ||||
Beta power | 26.7 [22.9, 30.4] | 25.4 [22.4, 28.4] | 18.9 [15.3, 22.5] | F(2, 102) = 8.1, p = 0.001 |
p(HC,MCI-AD) = 1.0 p(HC,MCI-LB) < 0.001 p(MCI-AD,MCI-LB) = 0.001 | ||||
Theta/alpha ratio | 0.34 [0.27, 0.40] | 0.42 [0.36, 0.47] | 0.51 [0.44, 0.57] | F(2, 102) = 7.5, p < 0.001 |
p(HC,MCI-AD) = 0.22 p(HC,MCI-LB) = 0.001 p(MCI-AD,MCI-LB) = 0.10 | ||||
DF, all electrodes | 8.4 [8.0, 8.9] | 8.0 [7.6, 8.3] | 7.2 [6.8, 7.6] | F(2, 102) = 8.7, p < 0.001 |
p(HC,MCI-AD) = 0.29 p(HC,MCI-LB) < 0.001 p(MCI-AD,MCI-LB) = 0.01 | ||||
DF, occipital electrodes | 8.5 [8.1, 9.0] | 8.0 [7.6, 8.3] | 7.3 [6.9, 7.7] | F(2, 102) = 8.7, p < 0.001 |
p(HC,MCI-AD) = 0.16 p(HC,MCI-LB) < 0.001 p(MCI-AD,MCI-LB) = 0.03 | ||||
DFV, occipital electrodes | 1.3 [0.9, 1.6] | 1.4 [1.1, 1.7] | 1.0 [0.8, 1.2] | F(2, 102) = 3.6, p = 0.03 |
p(HC,MCI-AD) = 0.54 p(HC,MCI-LB) = 1.0 p(MCI-AD,MCI-LB) = 0.17 |
Mean [95% confidence interval] of different quantitative EEG characteristics. Group comparisons were performed using univariate ANOVAs followed by post hoc tests, Bonferroni-corrected for multiple comparisons. Sex was included as a covariate
DF dominant frequency, DFV dominant frequency variability, HC healthy controls, MCI-AD mild cognitive impairment with Alzheimer’s disease, MCI-LB probable mild cognitive impairment with Lewy bodies